EUVIMEDEUVIMED entdecken
Crossref

DDX6 induces immunosuppression in cancer by disrupting structural stability of endogenous double-stranded RNAs

Larry Ng iD, Vincent Tano iD, Priyankaa Pitcheshwar, Wei Liang Gan iD, Jinghe Xie iD, Jesslyn Zhou iD, Kelvin Han Chung Chong iD, Danielle Huey Ren Chin iD, Xi Ren, Omer An iD, Sze Jing Tang iD, Vanessa Hui En Ng iD und 8 weitere

Science Immunology · 2026

DOI: 10.1126/sciimmunol.aea6909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, 2026. Verfasst von Larry Ng und 19 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: RNA, Double-Stranded, DEAD-box RNA Helicases, Neoplasms, Immune Tolerance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Gefördert von: Singapore Ministry of Education’s Tier 3 grants, NMRC Clinician Scientist-Individual Research Grant, NRF Competitive Research Programme (CRP) Grants.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular double-stranded RNA (dsRNA) can activate immune pathways similar to viral RNA. Adenosine deaminases acting on RNA 1 (ADAR1)–mediated adenosine-to-inosine (A-to-I) RNA editing has long been believed to destabilize endogenous dsRNA, thus preventing immune activation. We identified DEAD-box RNA helicase 6 (DDX6) as a potent editing repressor and an immune protector under normal conditions but as an immunosuppressor in cancer contexts. Through its interaction with ADAR1, DDX6 binds preferentially to cytoplasmic dsRNA, repressing editing of adenosines in A:C mismatches across the transcriptome, disrupting dsRNA structural stability, and suppressing interferon signaling and immune responses. Depleting DDX6 in tumor cells triggers dsRNA accumulation and activates both intrinsic and extrinsic immunity to hinder tumor growth. Our findings broaden our understanding of the paradigm that RNA editing not only destabilizes cellular dsRNAs but also can stabilize them through I-C pairing, a process preferentially suppressed by DDX6, to limit cytosolic dsRNA sensor recognition. Targeting DDX6 and harnessing RNA-associated tumor cell–intrinsic innate immune activation holds promise for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Double-StrandedDEAD-box RNA HelicasesNeoplasmsImmune ToleranceHumansAdenosine DeaminaseAnimalsRNA EditingRNA-Binding ProteinsCell Line, TumorProto-Oncogene Proteins

Substanzen

RNA, Double-StrandedDEAD-box RNA HelicasesDDX6 protein, humanAdenosine DeaminaseRNA-Binding ProteinsProto-Oncogene Proteins

Autor:innen und Institutionen

  • Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Catenion GmbH, Lietzenburger Straße 77, Berlin, Germany.
  • Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
  • NTU Institute of Structural Biology, Nanyang Technological University, Singapore, Singapore.
  • Putuo People's Hospital, School of Life Sciences and Technology, Frontier Science Center for Stem Cell Research, Tongji University, Shanghai, China.

ORCID-Profile: Larry Ng, Vincent Tano, Wei Liang Gan, Jinghe Xie, Jesslyn Zhou, Kelvin Han Chung Chong, Danielle Huey Ren Chin, Omer An, Sze Jing Tang, Vanessa Hui En Ng, Jian Han, Haoqing Shen, Yangyang Song, Daryl Jin Tai Tay, Bryan Y L Ng, Bin Wu, Dahai Luo, Leilei Chen

Förderung

  • Singapore Ministry of Education’s Tier 3 grants
  • NMRC Clinician Scientist-Individual Research Grant
  • NRF Competitive Research Programme (CRP) Grants
  • NMRC Open Fund-Large Collaborative Grants
  • the Health and Biomedical Sciences Industry Alignment Fund Pre-Positioning
  • Singapore Ministry of Education’s Tier 2 Grants

Zitieren

APA

Ng, L., Tano, V., Pitcheshwar, P., Gan, W. L., Xie, J., Zhou, J., Chong, K. H. C., Chin, D. H. R., Ren, X., An, O., Tang, S. J., Ng, V. H. E., Han, J., Shen, H., Song, Y., Tay, D. J. T., Ng, B. Y. L., Wu, B., Luo, D., & Chen, L. (2026). DDX6 induces immunosuppression in cancer by disrupting structural stability of endogenous double-stranded RNAs. Science Immunology. https://doi.org/10.1126/sciimmunol.aea6909

Vancouver

Ng L, Tano V, Pitcheshwar P, Gan WL, Xie J, Zhou J, et al. DDX6 induces immunosuppression in cancer by disrupting structural stability of endogenous double-stranded RNAs. Science Immunology. 2026. doi:10.1126/sciimmunol.aea6909

BibTeX
@article{Ng2026,
  author = {Ng, Larry and Tano, Vincent and Pitcheshwar, Priyankaa and Gan, Wei Liang and Xie, Jinghe and Zhou, Jesslyn and Chong, Kelvin Han Chung and Chin, Danielle Huey Ren and Ren, Xi and An, Omer and Tang, Sze Jing and Ng, Vanessa Hui En and Han, Jian and Shen, Haoqing and Song, Yangyang and Tay, Daryl Jin Tai and Ng, Bryan Y L and Wu, Bin and Luo, Dahai and Chen, Leilei},
  title = {DDX6 induces immunosuppression in cancer by disrupting structural stability of endogenous double-stranded RNAs},
  journal = {Science Immunology},
  year = {2026},
  doi = {10.1126/sciimmunol.aea6909}
}
Kostenlos starten →